Evaluation of antihypertensive medication adherence among hypertensive patients at Puskesmas Olak Kemang

Marizki Pondawinata; Nurul Kamilah Sadli; Novia Tri Astuti; M. Tri Firia Chandra

doi:10.22437/proca.v1i2.50461

Authors

Marizki Pondawinata Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi
Nurul Kamilah Sadli Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi
Novia Tri Astuti Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi
M. Tri Firia Chandra Department of Psychology, Faculty of Medicine and Health Sciences, Universitas Jambi

DOI:

https://doi.org/10.22437/proca.v1i2.50461

Keywords:

Adherence; antihypertensive medication; hypertension; Puskesmas Olak Kemang

Abstract

Background: Hypertension is a condition characterized by elevated systolic and/or diastolic blood pressure exceeding 140/90 mmHg. Medication adherence plays a crucial role in maintaining the long-term health of hypertensive patients, as non-adherence to antihypertensive therapy can lead to various complications such as stroke and even death. Objective: The study aimed to assess the level of antihypertensive medication adherence among hypertensive patients at Puskesmas Olak Kemang, especially in 2025. Methods: A descriptive study with a prospective approach was conducted, employing purposive sampling to select participants. Medication adherence was measured using the Morisky Medication Adherence Scale (MMAS-8), which consists of eight items.Results: The results revealed that 20% of patients demonstrated high adherence, 27% moderate adherence, and 53% low adherence to antihypertensive medication at Puskesmas Olak Kemang. Conclusion: Most hypertensive patients at Puskesmas Olak Kemang exhibit at a low level of medication adherence.

Downloads

Download data is not yet available.

Author Biographies

Marizki Pondawinata, Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

Nurul Kamilah Sadli, Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

Novia Tri Astuti, Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Jambi

M. Tri Firia Chandra, Department of Psychology, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Psychology, Faculty of Medicine and Health Sciences, Universitas Jambi

References

[1] Gabb G. What is hypertension? Aust Prescr 2020;43:108–9. https://doi.org/10.18773/austprescr.2020.025.

[2] Simbolon R, Halim R, Nuzulul Putra A, Kalsum U, Syukri M. Risk Factors Of Hypertension In Jambi City Based On Sehat Indonesiaku Application (Asik) Data In 2023. International Journal Of Health, Engineering And Technology 2025;4:97–109. https://doi.org/https://doi.org/10.55227/ijhet.v4i2.312.

[3] Rouette J, Mcdonald EG, Schuster T, Brophy JM, Azoulay L. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study. BMJ Open 2022;12. https://doi.org/10.1136/bmjopen-2021-057510.

[4] Sekkarie A, Fang J, Hayes D, Loustalot F. Prevalence of Self-Reported Hypertension and Antihypertensive Medication UseAmong Adults - Unites States, 2017-2021. MMWR Morb Mortal Wkly Rep 2014;73:191–8.

[5] Kim HJ, Kim BS, Kim H, Lee J, Shin JH, Sung KC. Impact of blood pressure and medication adherence on clinical outcomes in patients with hypertension. Front Med (Lausanne) 2025;12:1–12. https://doi.org/10.3389/fmed.2025.1564791.

[6] Sohn IS, Kim CJ, Yoo BS, Kim BJ, Choi JW, Kim D Il, Lee SH, Song WH, Jeon DW, Cha TJ, Kim DK, Lim SH, Nam CW, Shin JH, Kim U, Kwak JJ, Park JB, Cha JH, Kim YJ, Choi J, Lee J. Clinical impact of guideline-based practice and patients’ adherence in uncontrolled hypertension. Clin Hypertens 2021;27:1–7. https://doi.org/10.1186/s40885-021-00183-1.

[7] Setiadi AP, Febriandini A, Trinanda E, Aryaguna W, Mutho’atin Chusna I, Nurlaili Y, Sunderland B, Wibowo YI. Knowing the gap: medication use, adherence and blood pressure control among patients with hypertension in Indonesian primary care settings. PeerJ 2022;10:1–18. https://doi.org/10.7717/peerj.13171.

[8] Ramadhani A, Nasution LS. Level of Knowledge of Hypertension Patients and Compliance with Treatment at Sirnajaya Health Center. Muhammadiyah Medical Journal 2023;4:86. https://doi.org/10.24853/mmj.4.2.86-94.

[9] Zia Ulhaq L, Yusnitaswari U, Aulia G, Rizki Amalia T, Nurul Hakim A, Tsamrotul Fu I. Gambaran Tingkat Kepatuhan Minum Obat Pada Pasien Hipertensi di Wilayah Kerja Puskesmas Muka Kabupaten Cianjur Periode Januari - Februari 2022. PHRASE Pharma Sci J 2020;2:43–52. https://doi.org/https://doi.org/10.52031/phrase.v2i2.414.

[10] Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc 2022;11. https://doi.org/10.1161/JAHA.122.026582.

[11] Gardezi SKM, Aitken WW, Jilani MH. The Impact of Non-Adherence to Antihypertensive Drug Therapy. Healthcare (Switzerland) 2023;11:1–8. https://doi.org/10.3390/healthcare11222979.

[12] Hasniah H, Hardiana H, Rony R, Fadillah A, Erlianti K, Ramadhani J. Relationship Between Knowledge and Adherence to Antihypertensive at Public Healthcare in Banjarmasin City, Indonesia. Pharmacology and Clinical Pharmacy Research 2024;9:120–9. https://doi.org/10.15416/pcpr.v9i2.55548.

[13] Gavrilova A, Bandere D, Logviss K, Šmits D, Urtāne I. Adherence level to arterial hypertension treatment: A cross-sectional patient survey and retrospective analysis of the nhs prescription database. Healthcare (Switzerland) 2021;9:1–11. https://doi.org/10.3390/healthcare9081085.

[14] Andala S, Sofyan H, Hasballah K, Marthoenis. Knowledge and acceptance associated with medication adherence among hypertension individuals in Aceh province, Indonesia. Heliyon 2024;10:1–7. https://doi.org/10.1016/j.heliyon.2024.e29303.

[15] Espeche W, Salazar MR, Sabio R, Diaz A, Leiva Sisnieguez C, Olano D, Balbin E, Renna N, Grosse P, Flores RA, Lagos AC, Ferrer P, Poppe S, Risso Patron F, Sotnieczuk Stasiuk VD, Valentini E, Cardozo JR, Romano JR, Parodi R, Carbajal H. Adherence to antihypertensive drug treatment in Argentina: A multicenter study. J Clin Hypertens 2020;22:656–62. https://doi.org/10.1111/jch.13830.

[16] Pallarés-Carratalá V, Ruiz-García A, Serrano-Cumplido A, Arranz-Martínez E, Divisón-Garrote JA, Moyá-Amengual A, Escobar-Cervantes C, Barrios V. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study. Medicina (Lithuania) 2023;59:1–17. https://doi.org/10.3390/medicina59101846.

[17] Roa-Díaz ZM, Asllanaj E, Amin HA, Rojas LZ, Nano J, Ikram MA, Drenos F, Franco OH, Pazoki R, Marques-Vidal P, Voortman T, Muka T. Age at natural menopause and blood pressure traits: Mendelian randomization study. J Clin Med 2021;10. https://doi.org/10.3390/jcm10194299.

[18] Maximova K, Loyola Elizondo E, Rippin H, Breda J, Cappuccio FP, Hajihosseini M, Wickramasinghe K, Novik I, Pisaryk V, Sturua L, Akmatova A, Obreja G, Mustafo SA, Ekinci B, Erguder T, Shukurov S, Hagverdiyev G, Andreasyan D, Ferreira-Borges C, Berdzuli N, Whiting S, Fedkina N, Rakovac I. Exploring educational inequalities in hypertension control, salt knowledge and awareness, and patient advice: Insights from the WHO STEPS surveys of adults from nine Eastern European and Central Asian countries. Public Health Nutr 2023;26:S20–31. https://doi.org/10.1017/S1368980023000356.

[19] Radhi MM, Niazy SM, Abed SN. Individual-related factors associated with treatment adherence among hypertensive patients. J Public Health Afr 2023;14. https://doi.org/10.4081/jphia.2023.2466.

[20] Frati G, Biondi-Zoccai G, Peruzzi M, Valenti V. Comprehensive risk factor management for hypertensive patients. Eur Heart J Qual Care Clin Outcomes 2024;10:656–7. https://doi.org/10.1093/ehjqcco/qcae078.

[21] Wang W, Luan W, Zhang Z, Mei Y. Association between medication literacy and medication adherence and the mediating effect of self-efficacy in older people with multimorbidity. BMC Geriatr 2023;23:1–9. https://doi.org/10.1186/s12877-023-04072-0.

[22] Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Zohoun A, Essayagh M, Essayagh T, Essayagh S. Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. PLOS Global Public Health 2024;4:1–14. https://doi.org/10.1371/journal.pgph.0002774.

[23] Srie Herliany Y, Sary BL. Evaluasi Kepatuhan Minum Obat Pasien Hipertensi Program Pengelolaan Penyakit Kronis (PROLANIS) di Salah Satu Klinik Kota Bandung. Journal of Pharmaceutical Science and Clinical Pharmacy (PSCP) 2024;02:7–11. https://doi.org/https://doi.org/10.61329/pscp.v2i1.26.

[24] Alsaqabi YS, Rabbani U. Medication Adherence and Its Association With Quality of Life Among Hypertensive Patients Attending Primary Health Care Centers in Saudi Arabia. Cureus 2020;12:1–13. https://doi.org/10.7759/cureus.11853.

[25] Siregar AF, Asfriyati. The Influence of Sociodemographic Factors and Disease Characteristics on the Medication Adherence among Hypertensive Patients. Contagion: Scientific Periodical of Public Health and Coastal Health 2025;7:315–26. https://doi.org/10.30829/contagion.v7i1.23198.